{
  "id": "cluster_32_doc3",
  "content": "Research update: LIVER-209 study expanded to include patients with concurrent neurological symptoms after Policy WD-883 revision. 42 participants enrolled as of 11/2023, including Pt. XB-4882371. Dr. Varga presented preliminary findings at the International Hepatology Symposium in Prague, showing 34% reduction in copper levels among study cohort.",
  "metadata": {
    "format": "research_note"
  }
}